{"id":2776,"date":"2026-08-29T09:00:00","date_gmt":"2026-08-29T13:00:00","guid":{"rendered":"https:\/\/www.insilens.com\/?p=2776"},"modified":"2026-08-29T19:20:39","modified_gmt":"2026-08-29T23:20:39","slug":"perturb-seq-maps-co-regulated-programs-in-blood-stem-cells","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=2776","title":{"rendered":"Perturb-seq Maps Co-Regulated Programs in Blood Stem Cells"},"content":{"rendered":"

Institutions:<\/strong> Centre for Genomic Regulation \/ German Cancer Research Center \/ Berlin Institute of Health \/ Charite \/ Heidelberg University Hospital · Technology:<\/strong> Perturb-seq (CRISPR Interference) · Application:<\/strong> Hematopoietic Stem and Progenitor Cell Regulatory Programs · Date:<\/strong> August 29, 2026<\/p>\n

\"20260829_CRG_DKFZ_HSPC_Perturb_seq_Technology_and_Modalities\"<\/p>\n

Summary<\/h4>\n

A non-peer-reviewed study used CRISPR interference Perturb-seq to suppress 520 genes in primary mouse hematopoietic stem and progenitor cell cultures and resolve local transcriptional effects separately from shifts in cell-state abundance. The authors derived 19 perturbation-defined gene-regulatory programs spanning core processes such as protein biosynthesis, cell cycle, inflammatory signaling and stem-cell identity. Program activity associated with clonal output after transplantation and improved retrospective prediction of acute myeloid leukemia survival and venetoclax response, but the work is a research resource for target and biomarker discovery, not evidence that any program is therapeutically causal or ready for clinical use.<\/p>\n

What Happened<\/h4>\n

The consortium analyzed ex vivo mouse HSPC expansion cultures with three guide RNAs per target and developed a framework that separates perturbation-associated changes in population composition from transcriptional changes within a defined cell state, a distinction that matters in heterogeneous marrow systems where a perturbation can appear to alter a pathway merely by expanding or depleting one progenitor population. The resulting local signatures were clustered into 19 co-regulated programs, at least 13 of which aligned with recognizable cell-biological processes. The authors then projected those programs into independent human and mouse functional or clinical expression datasets, reporting associations with HSC self-renewal and engraftment, and incremental prediction of long-term survival and venetoclax response in retrospective AML cohorts beyond comparator transcriptomic measures. The underlying differential-expression and differential-abundance outputs were deposited publicly. The preprint has not been peer reviewed, and the clinical analyses are retrospective rather than prospective validation.<\/p>\n

Deep Analysis<\/h4>\n

Because the programs are defined by coordinated responses to genetic perturbation rather than by co-expression alone, they may better separate regulatory relationships from correlations produced by lineage mixture, and the primary-cell design, guide-level replication and public data increase reuse value for target nomination, synthetic-lethality searches and biomarker construction. Counterevidence is that CRISPR interference establishes consequences of partial gene suppression in cultured mouse cells; it does not prove that an inferred program is druggable, disease-driving or preserved in human marrow niches. The apparent predictive gain could also partly reflect dataset-specific expression structure, model flexibility or overlap with known proliferation and differentiation axes, and retrospective survival and drug-response associations are vulnerable to treatment heterogeneity, cohort composition and unmeasured clinical covariates. No prospective patient classification, in vivo perturbation of nominated programs, normal-versus-leukemic therapeutic window, pharmacology or delivery experiment is presented, so on a conservative reading the strongest output is a reusable research resource rather than a validated therapeutic platform.<\/p>\n

Company and Product Background<\/h4>\n

The work was led by investigators from the Centre for Genomic Regulation and collaborators at the Berlin Institute of Health, Charite, Heidelberg University Hospital, the German Cancer Research Center and related institutions. It is an academic technology and biology signal rather than a company product announcement. Perturb-seq combines pooled CRISPR perturbation with single-cell RNA sequencing so each cell’s genetic intervention can be linked to its transcriptional response. HSPCs sustain blood production through self-renewal and differentiation into erythroid, megakaryocytic, myeloid and lymphoid lineages; dysregulated stem and progenitor programs contribute to clonal hematopoiesis and AML, while normal HSPC preservation constrains the therapeutic window of many leukemia treatments. Venetoclax inhibits BCL-2 and is widely combined with hypomethylating agents in AML, with resistance arising through shifts in apoptotic dependence, cellular state and metabolic programs.<\/p>\n

Signal Extraction<\/h4>\n\n\n\n\n\n\n\n
Factor<\/th>\nAssessment<\/th>\n<\/tr>\n
Screen Scale<\/td>\n520-gene CRISPRi Perturb-seq screen in primary mouse HSPC cultures<\/td>\n<\/tr>\n
Output<\/td>\n19 co-regulated gene-regulatory programs, at least 13 mapped to known cell-biological processes<\/td>\n<\/tr>\n
Clinical Association<\/td>\nRetrospective incremental prediction of AML survival and venetoclax response<\/td>\n<\/tr>\n
Validation Status<\/td>\nNon-peer-reviewed preprint; no prospective or in vivo causal validation<\/td>\n<\/tr>\n
Signal Type<\/td>\nAcademic methods and biology resource, not a therapeutic candidate<\/td>\n<\/tr>\n<\/table>\n

Reading the Signal<\/h4>\n

Bull case:<\/strong> A perturbation-defined regulatory map that separates cell-state composition from transcriptional response, paired with public datasets and links to transplantation and AML outcomes, could sharpen target and biomarker hypotheses in a field where bulk expression data often confounds lineage with mechanism.<\/p>\n

Bear case:<\/strong> The screen is mouse, ex vivo and non-peer-reviewed, the AML links are retrospective, and no experiment yet demonstrates that any specific program is causal, druggable or conserved in human marrow, meaning the predictive gains could reflect dataset-specific structure rather than genuine biology.<\/p>\n

InSilens Take<\/h4>\n

The useful advance is not another AML signature; it is the attempt to extract regulatory programs from controlled perturbations while accounting for marrow-state composition, which can sharpen hypotheses in a field where lineage and mechanism are often confounded. But the result remains upstream of therapy, and the defensible direction is uncertain until individual program nodes show causal disease selectivity, a human therapeutic window and prospective predictive value.<\/p>\n

Signal Assessment<\/h4>\n

Importance:<\/strong> 3\/5 · Direction:<\/strong> Uncertain · Confidence:<\/strong> Moderate-high on facts, Low-moderate on interpretation<\/p>\n","protected":false},"excerpt":{"rendered":"

A non-peer-reviewed study used CRISPR interference Perturb-seq to suppress 520 genes in primary mouse hematopoietic stem and progenitor cell cultures and resolve local transcriptional effects separately from shifts in cell-state abundance. The authors derived…<\/p>\n","protected":false},"author":1,"featured_media":2780,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[76,341,466,467],"class_list":["post-2776","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology-modalities","tag-acute-myeloid-leukemia","tag-hematopoietic-stem-cells","tag-perturb-seq","tag-venetoclax"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/2776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2776"}],"version-history":[{"count":1,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/2776\/revisions"}],"predecessor-version":[{"id":2782,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/2776\/revisions\/2782"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/2780"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}